-----Message d'origine-----
De : MR NORMAND A PELISSIER +ADw-LMHE05A+AEA-prodigy.com+AD4-
+AMA- : HospitalFR+AEA-pharmweb1.man.ac.uk +ADw-HospitalFR+AEA-pharmweb1.man.ac.uk+AD4-
Date : mardi 8 d+AOk-cembre 1998 03:05
Objet : PharmWeb Forum Discussion Groups
I understand that the drug +ACI-troglitazone,+ACI- an anti-diabetic agent,
was removed from the British market. It is still an approved drug
in the U.S. although our FDA has been expanding on the precautionary
warnings that must accompany the product literature. Is it required
in your country that specific product literature accompany each
package of medication as it is in the U.S. ?
+AF8AXwBfAF8-
Norm Pelissier +AD0APQ- lmhe05A+AEA-Prodigy.com +AD0APQ- normpel+AEA-aol.com +AD0APQ-
normp+AEA-Juno.com +AD0APQ- normp+AEA-helix.org +AD0APQ- (+AF4AXwBe-)
|